AAAAAA

   
Results: 1-9 |
Results: 9
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy
Authors: Mantovani, G Maccio, A Madeddu, C Massa, E Mudu, MC Mulas, C Gramignano, G Massidda, S Murgia, V Lusso, MR Mura, L
Citation: G. Mantovani et al., Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy, INT J ONCOL, 18(2), 2001, pp. 383-391
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites
Authors: Mantovani, G Maccio, A Madeddu, C Mura, L Massa, E Mudu, MC Mulas, C Lusso, MR Gramignano, G Piras, MB
Citation: G. Mantovani et al., Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites, J MOL MED-J, 79(7), 2001, pp. 406-414
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical outcome, toxicity and organ/function preservation
Authors: Mantovani, G Maccio, A Mulas, C Massa, E Mudu, MC Massidda, S Massa, D Murgia, V Ferreli, L Astara, G Proto, E Tore, G Mura, M Amichetti, M
Citation: G. Mantovani et al., Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical outcome, toxicity and organ/function preservation, TUMORI, 87(4), 2001, pp. S43-S44
Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetateand recombinant interleukin-2 in patients with inoperable primary lung cancer
Authors: Mantovani, G Maccio, A Lai, P Massa, E Massa, D Mulas, C Succu, G Mudu, MC Manca, G Versace, R Pisano, M
Citation: G. Mantovani et al., Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetateand recombinant interleukin-2 in patients with inoperable primary lung cancer, J IMMUNOTH, 23(2), 2000, pp. 267-274
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical outcome, toxicity and organ/function preservation
Authors: Mantovani, G Maccio, A Massa, E Mulas, C Mudu, MC Massidda, S Massa, D Murgia, V Ferreli, L Succu, G Astara, G Proto, E Tore, G Mura, M Maxia, G
Citation: G. Mantovani et al., Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical outcome, toxicity and organ/function preservation, INT J ONCOL, 16(6), 2000, pp. 1227-1233
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites
Authors: Mantovani, G Maccio, A Mura, L Massa, E Mudu, MC Mulas, C Lusso, MR Madeddu, C Dessi, A
Citation: G. Mantovani et al., Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites, J MOL MED-J, 78(10), 2000, pp. 554-561
Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine
Authors: Mantovani, G Maccio, A Melis, G Mura, L Massa, E Mudu, MC
Citation: G. Mantovani et al., Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine, INT J CANC, 86(6), 2000, pp. 842-847
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical response and organ/function preservation
Authors: Mantovani, G Maccio, A Massa, E Mulas, C Mudu, MC Massidda, S Massa, D Murgia, V Ferreli, L Succu, G Astara, G Proto, E Tore, G Mura, M Maxia, G
Citation: G. Mantovani et al., Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical response and organ/function preservation, ONCOL REP, 6(6), 1999, pp. 1425-1430
Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients
Authors: Mantovani, G Ghiani, M Curreli, L Maccio, A Massa, D Succu, G Lai, P Massa, E Mudu, MC Astara, G
Citation: G. Mantovani et al., Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients, ONCOL REP, 6(2), 1999, pp. 421-426
Risultati: 1-9 |